Brilacidin is certainly targeting the moderate to

Brilacidin is certainly targeting the moderate to severe cases of CV19 as it appears nothing else is on the near horizon that can do that, but that does not mean it shouldn't work just as effectively for patients in the very early stages of contracting the virus or be used as a deterrent if they just feel like they may be coming down with the virus. It's cost, ease of storage and delivery, and safety profile should make it the TOTAL treatment for any stage of CV19 IMO